GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » EBITDA Margin %

DOD Biotech PCL (BKK:DOD-R) EBITDA Margin % : 17.97% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. DOD Biotech PCL's EBITDA for the three months ended in Mar. 2025 was ฿30.7 Mil. DOD Biotech PCL's Revenue for the three months ended in Mar. 2025 was ฿171.1 Mil. Therefore, DOD Biotech PCL's EBITDA margin for the quarter that ended in Mar. 2025 was 17.97%.


DOD Biotech PCL EBITDA Margin % Historical Data

The historical data trend for DOD Biotech PCL's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL EBITDA Margin % Chart

DOD Biotech PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.88 33.37 -65.65 25.86 16.25

DOD Biotech PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.17 -110.13 20.54 7.10 17.97

Competitive Comparison of DOD Biotech PCL's EBITDA Margin %

For the Packaged Foods subindustry, DOD Biotech PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DOD Biotech PCL's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's EBITDA Margin % falls into.


;
;

DOD Biotech PCL EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

DOD Biotech PCL's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=104.893/645.385
=16.25 %

DOD Biotech PCL's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=30.736/171.066
=17.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DOD Biotech PCL  (BKK:DOD-R) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


DOD Biotech PCL EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


DOD Biotech PCL Business Description

Traded in Other Exchanges
Address
No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines